UniSuper Management Pty Ltd Increases Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

UniSuper Management Pty Ltd increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 30.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 24,294 shares of the medical device company’s stock after acquiring an additional 5,672 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Cooper Companies were worth $2,233,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new stake in shares of Cooper Companies in the fourth quarter worth approximately $64,826,000. Victory Capital Management Inc. lifted its holdings in Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock valued at $415,985,000 after purchasing an additional 574,899 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after purchasing an additional 573,908 shares during the last quarter. Wealthfront Advisers LLC raised its position in shares of Cooper Companies by 4,594.1% in the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company’s stock valued at $52,383,000 after buying an additional 557,673 shares during the last quarter. Finally, Alecta Tjanstepension Omsesidigt purchased a new position in shares of Cooper Companies in the fourth quarter worth about $49,550,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Stifel Nicolaus cut their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. Robert W. Baird lowered their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research note on Friday, March 7th. Citigroup cut their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. JPMorgan Chase & Co. dropped their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Friday, March 7th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Stock Performance

Shares of COO stock opened at $83.77 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $16.75 billion, a P/E ratio of 42.96, a P/E/G ratio of 2.25 and a beta of 1.02. The firm’s 50 day moving average price is $89.33 and its 200-day moving average price is $97.21. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.